Literature DB >> 30323308

Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.

Alejandro De la Hoz1,2, Farnaz Foolad3, Cinthia Gallegos2,4, Steven Kornblau5, Dimitrios P Kontoyiannis6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30323308     DOI： 10.1038/s41409-018-0363-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Severe encephalopathy after high-dose chemotherapy with autologous stem cell support for brain tumours.

Authors:  F van den Berkmortel; C Gidding; M De Kanter; C J A Punt
Journal:  Anticancer Res       Date:  2006 Jan-Feb       Impact factor: 2.480

Review 2.  A review of serious adverse effects under treatment with checkpoint inhibitors.

Authors:  Lucie Heinzerling; Simone M Goldinger
Journal:  Curr Opin Oncol       Date:  2017-03       Impact factor: 3.645

Review 3.  Treatment strategies for autoimmune encephalitis.

Authors:  Yong-Won Shin; Soon-Tae Lee; Kyung-Il Park; Keun-Hwa Jung; Ki-Young Jung; Sang Kun Lee; Kon Chu
Journal:  Ther Adv Neurol Disord       Date:  2017-08-16       Impact factor: 6.570
  3 in total
  2 in total

1.  Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.

Authors:  Laure Thouvenin; Timothée Olivier; Giuseppe Banna; Alfredo Addeo; Alex Friedlaender
Journal:  Ther Adv Drug Saf       Date:  2021-03-29

Review 2.  Immune Checkpoint Inhibitors and Neurotoxicity.

Authors:  Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.